The Centre for Medicine Use and Safety within the Monash Institute of Pharmaceutical Sciences has released research that shows a decline in the use of opioid and psychotropic medicines following the reimbursement of ‘modulator therapy’ for cystic fibrosis. …
Decline in the use of opioids and psychotropics in patients treated with new CF therapies
November 29, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Pharmac funds and widens access to melanoma medicines
May 11, 2025 - - Latest News -
Non-descript vagueness on pharmaceuticals in US-UK bilateral trade agreement
May 11, 2025 - - Latest News -
Who are 'legislated conditional listings' designed to limit, the industry or the minister?
May 11, 2025 - - Latest News -
Vertex welcomes expanded TGA approval for cystic fibrosis therapy
May 9, 2025 - - Latest News -
Sanofi's consumer health business Opella becomes a standalone company
May 9, 2025 - - Latest News -
New partnership promotes buy local for homegrown innovation
May 8, 2025 - - Latest News -
New Zealand to change laws to promote medical conferences
May 8, 2025 - - Latest News